Table 3. Percentage of FMR1 premutated carriers with self-reported FXTAS symptoms.

	FXTAS symptoms
	Male	Female	Total
50–59 years	0% (0/1)	3.7% (1/27)	3.6% (1/28)
60–69 years	52.9% (9/17)	20% (3/15)	37.5% (12/32)
70–79 years	53.3% (8/15)	26.3% (5/19)	38.2% (13/34)
≥80 years	27.3% (3/11)	20.8% (5/24)	22.9% (8/35)